Kalaris Therapeutics

KLRS

Börsenwert 44,5 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
26	26 Stonepine Capital Management Bend, Oregon	122.597 $	+50.495 $	+9.722	+48 %
27	27 Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada	122.128 $	+84.931 $	+16.352	+120 %
28	28 Trexquant Investment Stamford, Connecticut	121.030 $	+154.451 $	+29.737	Neu
29	29 State Street Boston, Massachusetts	107.896 $	–	–	–
30	30 Northern Trust Chicago, Illinois	105.165 $	+59.159 $	+11.390	+79 %
31	31 Velan Capital Investment Management Alpharetta, Georgia	101.750 $	+36.357 $	+7.000	+39 %
32	32 Two Sigma Investments New York	97.057 $	-35.334 $	-6.803	-22 %
33	33 WealthTrust Asset Management Destin, Florida	83.093 $	+41.551 $	+8.000	+64 %
34	34 Independent Advisor Alliance Charlotte, North Carolina	73.769 $	+20.230 $	+3.895	+27 %
35	35 RBF Capital San Francisco, California	70.781 $	–	–	–
36	36 Quadrature Capital London, United Kingdom	67.265 $	+85.840 $	+16.527	Neu
37	37 Goldman Sachs New York	65.340 $	-490.559 $	-94.449	-85 %
38	38 Dimensional Fund Advisors Austin, Texas	64.991 $	+82.884 $	+15.958	Neu
39	39 Susquehanna International Group Bala Cynwyd, Pennsylvania	57.879 $	-199.773 $	-38.463	-73 %
40	40 HRT Financial New York	55.000 $	+10.938 $	+2.106	+18 %
41	NCNMGF 41 Nano-Cap New Millennium Growth Fund Staten Island, New York	50.875 $	+44.148 $	+8.500	+213 %
42	42 Virtu Financial New York	44.000 $	+56.328 $	+10.845	Neu
43	43 Sigma Planning Corp Ann Arbor, Michigan	41.380 $	+52.806 $	+10.167	Neu
44	44 Fidelity Investments Boston, Massachusetts	31.770 $	–	–	–
45	45 Tower Research Capital (TRC) New York	10.419 $	+12.574 $	+2.421	+1.742 %
46	46 Steward Partners Investment Advisory New York	9.015 $	–	–	–
47	47 Vanguard Global Advisers Malvern, Pennsylvania	2.951 $	–	–	–
48	48 Barclays London, United Kingdom	1.233 $	-25.850 $	-4.977	-94 %
49	49 Strengthening Families & Communities LLC Boston, Massachusetts	1.091 $	–	–	–
50	50 BNP Paribas Financial Markets Paris, France	212 $	-3.116 $	-600	-92 %

Kalaris Therapeutics KLRS Börsenwert 44,5 Mio. $

Kalaris Therapeutics

KLRS

Börsenwert 44,5 Mio. $